Page last updated: 2024-10-23

bisoprolol and Telangiectasis

bisoprolol has been researched along with Telangiectasis in 1 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Telangiectasis: Permanent dilation of preexisting blood vessels (CAPILLARIES; ARTERIOLES; VENULES) creating small focal red lesions, most commonly in the skin or mucous membranes. It is characterized by the prominence of skin blood vessels, such as vascular spiders.

Research Excerpts

ExcerptRelevanceReference
" The patient had been treated with amlodipine (Amlor(®)) and a combination of bisoprolol and hydrochlorothiazide (Lodoz(®)) for 5years for essential hypertension."3.79[Telangiectasia during amlodipine therapy]. ( Dussouil, AS; Gaudy-Marqueste, C; Grob, JJ; Mallet, S; Monestier, S; Richard, MA; Tasei, AM, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dussouil, AS1
Gaudy-Marqueste, C1
Tasei, AM1
Monestier, S1
Mallet, S1
Grob, JJ1
Richard, MA1

Other Studies

1 other study available for bisoprolol and Telangiectasis

ArticleYear
[Telangiectasia during amlodipine therapy].
    Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:3

    Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Calcium Channel Blockers; Drug Substitution; Drug T

2013